Jaguar Health, Inc.
JAGX
$2.75
-$0.07-2.48%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -34.12M | -53.43M | -40.29M | -40.65M | -39.73M |
| Total Depreciation and Amortization | 2.18M | 2.20M | 2.25M | 2.29M | 2.29M |
| Total Amortization of Deferred Charges | 153.00K | 153.00K | 0.00 | 0.00 | 0.00 |
| Total Other Non-Cash Items | 10.40M | 10.88M | 9.47M | 10.35M | 9.32M |
| Change in Net Operating Assets | 13.85M | 16.51M | 2.55M | 327.00K | -1.54M |
| Cash from Operations | -7.54M | -23.68M | -26.02M | -27.67M | -29.65M |
| Capital Expenditure | -41.00K | -41.00K | -54.00K | 0.00 | -16.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -215.00K | -215.00K | -215.00K |
| Cash from Investing | -41.00K | -41.00K | -269.00K | -215.00K | -231.00K |
| Total Debt Issued | 10.00M | 13.45M | 3.45M | 3.45M | 3.45M |
| Total Debt Repaid | -6.95M | -752.00K | -753.00K | -775.00K | -724.00K |
| Issuance of Common Stock | 7.03M | 8.80M | 11.83M | 11.41M | 21.31M |
| Repurchase of Common Stock | -56.00K | -56.00K | -- | -- | -- |
| Issuance of Preferred Stock | 2.38M | 2.38M | 2.38M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -308.00K | -145.00K | -191.00K | -95.00K | -132.00K |
| Cash from Financing | 12.09M | 23.67M | 16.71M | 13.98M | 23.90M |
| Foreign Exchange rate Adjustments | -132.00K | -113.00K | -159.00K | 68.00K | 1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.38M | -168.00K | -9.74M | -13.84M | -5.98M |